PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...

PARIS--(BUSINESS WIRE)--LimFlow SA today announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System, a novel, purely ...

Inari Medical has agreed to acquire LimFlow, maker of a device to treat patients with chronic limb-threatening loss of blood flow, for $250 million in cash plus potential milestone payments, bringing ...

MIAMI, Nov. 7, 2024 /PRNewswire/ -- Pedro Martinez-Clark, MD, FACC, a renowned Harvard-trained cardiologist and founder of Amavita Heart and Vascular™, has joined forces with LimFlow® to offer an ...

PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)-- LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...

The US Food and Drug Administration (FDA) has approved an endovascular device for patients with chronic limb-threatening ischemia (CLTI) at risk for major amputation who are poor candidates for ...

PARIS–(BUSINESS WIRE)–#CLI—LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), the most severe form of peripheral ...

The LimFlow system employs a covered stent that shunts oxygenated blood around a blocked artery by directing it into a nearby vein. (LimFlow) Inari Medical has signed on to a $415 million deal to ...

New Therapeutic Option Has Potential to Reduce Rate of Major Limb Amputation in U.S. LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic ...